Intensive care therapy for cancer patients;Suporte de terapia intensiva no paciente oncológico

Jornal de Pediatria

Volumn 79, Issue SUPPL. 2, 2003, Pages

  Sapolnik, Roberto ^a,b,c  

^a HOSPITAL SÃO RAFAEL   (Brazil)

^b AMIB   (France)

^c NONE   (Brazil)

Author keywords

Cancer; Children; Complication; Infection; Intensive care; Organic dysfunction

Indexed keywords

BACTERIAL INFECTION; BLOOD DISEASE; CANCER PATIENT; CARDIOVASCULAR DISEASE; ELECTROLYTE DISTURBANCE; EMOTIONALITY; GASTROINTESTINAL DISEASE; HUMAN; KIDNEY DISEASE; MEDLINE; METABOLIC DISORDER; NEUROLOGIC DISEASE; NEWBORN INTENSIVE CARE; NUTRITIONAL SUPPORT; RESPIRATORY TRACT DISEASE; REVIEW;

EID: 0347595680     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/jped.1100     Document Type: Review

References (56)

1. Meyer A. Death and disability from injury: a global challenge. J Trauma 1998;44:1-12.
2. Hallahan AR, Shaw PJ, Rowell G, O'Connell A, Schell D, Gillis J. Improved outcome of children with malignance admitted to a pediatric intensive care unit. Crit Care Med 2000;28:3718-21.
3. Reaman HG. Pediatric oncology: current view and outcomes. Pediatric Cli North Am 2002;49:1-39.
4. a ed. Filadélfia: Lippincott-Raven Pub.; 1997. p. 1069-1114.
5. Armstrong D, Young LS, Meyer RD, Blevins AH. Infectious complications of neoplastic disease. Med Clin North Am 1971;55;729-45.
6. Rose C, Auxenfants E, Noel MP, Mahieu M, Demory JL, Croxo C, et al. Tuberculosis, Mycobacterium infection and hair cell leukemia. Presse Med 1997;26:110-4.
7. Sickles EA, Greene WH, Wiernik PH. Clinical presentation of infection in granulocytopenic patients. Arch Inter Med 1975;135:715-9.
8. Lehrnbecher T, Venzon D, de Haas M, Chanock SJ, Kuhl J. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia. Cli Infect Dis 1999;31:185-9.
9. Lucas KG, Brown AE, Armstrong D, Chapman D, Heller G. The identification of febrile, neutropenic children with neoplasic disease low risk of bacteremia and complications of sepsis. Cancer 1996;77:791-9.
10. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Inf Dis 2002; 34:1-39.
11. Talcott JA, Siegel RD, Finberg R, Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol 1992;10: 316-22.
12. Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KW, et al. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Cancer 1999;86:126-34.
13. Rubinstein E, Cammarata S, Oliphant T, Wunderink R; Linezolid Nosocomial Pneumonia Study Group. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clin Infect Dis 2001;32:402-12.
14. Chow AW, Jewesson PJ, Kureishi A, Phillips GL. Teicoplamina versus vancomycin in the empirical treatment of febrile neutropenic patients. Eur J Haematol Suppl 1991;54:18-24.
15. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982;72: 101-11.
16. Winston DJ, Hathorn JW, Schuster MG, Schiller GJ, Territo MC. A multicenter randomized trial of gluconazole versus anfotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer. Am J Med 2000;108:282-9.
17. Liang DC, Chen SH, Lean SF. Role of granulocyte colony-stimulating factor as adjunct therapy for septicemia in children with acute leukemia. Am J Hematol 1995;48:76-81.
18. Sachdeva RC, Jefferson LS, Coss-Bu J, Brody BA. Resource consumption and the extent of futile care in a pediatric intensive care setting. J Pediatr 1996;128:742-7.
19. Goad KE, Gralnick HR. Coagulation disorders in cancer. Hematol Oncol Clin North Am 1996;10:457.
20. Slichter SJ, Harker LA. Hemostasis in malignancy. Ann N Y Acad Sci 1974;230:252-61.
21. Johnson MJ. Bleeding, clotting, and cancer. Clin Oncol (R Coll Radiol). 1997;9(5):294-301.
22. DeSancho MT, Rand HJ. Bleeding and thrombotic complications in critically ill patients with cancer. Crit Care Clin 2001;17: 599-622.
23. Veyradier A, Jenkins CS, Fressinaud E, Meyer D. Acquired von Willebrand syndrome: From pathophysiology to management. Throm Haemost 2000;84:175-82.
24. Development Task Force of the College of American Pathologists; Practice parameter for the use of fresh frozen plasma, cryopreciptate, and platelets. Fresh-Frozen Plasma, Cryopreciptate, and Platelets Administration Practice Guidelines. JAMA 1994;271:777.
25. Baron JA, Gridley G, Weiderpass E, Nyren O, Linet M. Venous thromboembolism and cancer. Lancet 1998;351:1077-80.
26. Bona RD. Thrombotic complications of central venous catheter in cancer patients. Semin Thomb Hemost 1999;25:147-55.
27. Arkel YS. Thrombosis and cancer. Semin Oncol 2000;27:362-74.
28. Colman RW, Rubin RN. Disseminated intravascular coagulation due to malignancy. Semin Oncol 1990;17:172.
29. Ingram L, Rivera GK, Shapiro DN. Superior vena cava syndrome associated with childhood malignancy: analysis of 24 cases. Med Pediatr Oncol 1990;18;476-81.
30. Bunin NJ, Pui CH. Differing complications of hyperleukocytosis in children with acute lynfoblastic or non-lynfoblastic leukemia. J Clin Oncol 1985;3:1590:5.
31. Dafnins EK, Laski ME. Fluid and electrolyte abnormalities in the oncology patient. Sem Nephrol 1993;13:2811-296.
32. Daugaard G, Abildgaard U, Holstein-Rathlou NH, Bruunshuus I, Bucher D, Leyssac PP. Renal tubular function in patients treated with high-dose cisplatin. Cli Pharmacol Ther 1988;44: 164-72.
33. Cassileth PA, Trotman BW. Inappropriate antidiuretic hormone secretion in Hodgkin's disease. Am J Med Sci 1973;265:233-5.
34. Zazgornik J, Jellinger K, Waldhausl N. Excessive hypernatremia and hyperosmolality associated with germinoma in the hypothalamus and pituitary region. Eur Neurol 1974;12:38-46.
35. Cobos E, Hall RR. Effects of chemotherapy on the kidney. Semin Nephrol 1993;13:297-305.
36. Bellevue R, Dosik H, Spergel G, Gussoff BD. Pseudohyperkalemia and extreme leukocytosis. J Lab Clin Med 1975;85:660-4.
37. Blumberg A, Weidmann P, Shaw S, Gnadinger M. Effects of various therapeutics approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med 1988;85:507-12.
38. Reber PM, Heath H 3rd. Hypocalcemics emergencies. Med Clin North Am 1995;79:93-106.
39. Rosol TJ, Capen CC. Mechanisms of cancer-induced hypercalcemia. Lab Invest 1992;67:680-702.
40. Wong ET, Rude RK, Singer FR, Shaw ST Jr. A high prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients. Am J Clin Pathol 1983;79:348-52.
41. Patterson WP, Khojasteh ALI. Ifosfamide-inducedrenal tubular defects. Cancer 1989;63:649-51.
42. Goldman R, Basset SH. Phosphorus excretion in renal failure. J Clin Invest 1974;33:1623.
43. Hande KR, Garrow GC. Acute tumor lyses syndrome in patients with high-grade non-Hodgkin's lymphoma. Am J Med 1993;94:133-9.
44. Kjjelstrand CM, Campbell DC, von Hartzsch B. Hyperuricemic acute renal failure. Arch Intern Med 1974;133:349-59.
45. Spector T. Inhibition of urate production by allopurinol. Biochem Pharmacol 1977;26:355-8.
46. Adrogue HJ, Madias NE. Management of life-threatening acid-base disorders. N Engl J Med 1998;338;107-11.
47. Patterson WP, Kojasteh ALI. Ifosfamide-induced renal tubular defects. Cancer 1989;63:649-51.
48. a ed. San Francisco: Churchill-Livingstone; 1997.
49. Armitage JO. Bone marrow transplantation. N Engl J Med 1994;330:827-38.
50. Price KJ, Thall PF, Kish SK, Shannon VR, Andersson BS. Prognostic indicators of blood and marrow transplant patients admitted to the intensive care unit. Am J Respir Crit Care Med 1998;158(3):876-84.
51. Tisdale MJ. Wasting in cancer. J Nutr 1999;129:243S-246S.
52. Trujillo EB, Robinson MK, Jacobs DO. Nutritional assessment in the critical ill. Crit Care Nurse 1999;19:67-78.
53. Li J, Kudsk KA, Gocinski B, Dent D, Glezer J, Langkamp-Henken B. Effects of enteral and parenteral nutrition on gut-associated lymphoid tissue. J Trauma 1995;39:44-52.
54. Nunnally C, Donoghue M, Yasko JM. Nutritional needs of cancer patients. Nurs Clin North Am 1982;17:557-8.
55. Ethical and moral guidelines for the initiation, continuation, and withdrawal of intensive care. American College of Chest Physicians/Society of Critical care Medicine Consensus Panel. Chest 1990;97:949.
56. Weisman SJ. Cancer pain in children: etiology, guidelines, and symptom control. In: Yaster M, editor. Problems in anesthesia: current issues in pediatric anesthesia. Filadélfia: Lippincott Williams & Wilkins; 1998. p. 498-506.